Coronary artery bypass grafting within 30 days after treatment of acute myocardial infarctions with angioplasty or fibrinolysis - a surgical substudy of DANAMI-2

Author: Kjaergard Henrik   Nielsen Per Hostrup   Andreasen Jan Jesper   Steinbrüchel Daniel   Andersen Lars Ib   Rasmussen Klaus   Andersen Henning Rud   Toftegaard Nielsen Torsten  

Publisher: Informa Healthcare

ISSN: 1401-7431

Source: Scandinavian Cardiovascular Journal, Vol.38, Iss.3, 2004-06, pp. : 143-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Objective--To calculate the incidence and analyse the indications and outcome after surgical revascularization within the first 30 days after randomization of 1572 patients with acute myocardial infarction (MI) associated with ST-segment elevation (STEMI).Design--Data regarding the patients undergoing heart surgery within the first 30 days after randomization were collected.Results--Three patients (0.2%) with acute STEMI and randomized to percutaneous coronary intervention (PCI) underwent emergent coronary artery bypass grafting (CABG). A total of 50 patients (3.2%), 30 in the PCI group and 20 in the fibrinolysis group were revascularized by surgery within the first 30 days after randomization. The most frequent indication for surgery in both groups was unstable angina pectoris, followed by left main stenosis. The incidence of postoperative complications was higher compared with the outcome after elective CABG.Conclusions--The incidence of emergency CABG in this study was low (0.2%) after treatment of acute MI with either PCI or fibrinolysis. The overall incidence within 30 days was 3.2%, however, the mortality is increased with a 30-day mortality of 10% in this high-risk patient group.

Related content